Meeting of the Oncologic Drugs Advisory Committee (ODAC) - Video

13 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

At this meeting, the committee will discuss new drug application (NDA) 215500, for eflornithine tablets, submitted by USWM, LLC (doing business as US WorldMeds). The proposed indication (use) for this product is to reduce the risk of relapse in pediatric patients with high-risk neuroblastoma (HRNB) who have completed multiagent, multimodality therapy.
Category
Try Not To Cum
Commenting disabled.